We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNC.WS
3101
DELISTED
Lincoln National Corporation
LNC.WS
$5K ﹤0.01%
72
SFS
3102
DELISTED
Smart & Final Stores, Inc.
SFS
$5K ﹤0.01%
944
-7,628
-89% -$38.6K
SPA
3103
DELISTED
Sparton
SPA
$5K ﹤0.01%
+269
New +$4.96K
INDUU
3104
DELISTED
Industrea Acquisition Corp. Unit
INDUU
$5K ﹤0.01%
494
OSPRU
3105
DELISTED
Osprey Energy Acquisition Corp. Unit
OSPRU
$5K ﹤0.01%
496
+296
+148% +$3.07K
TAX
3106
DELISTED
Liberty Tax, Inc. Class A
TAX
$5K ﹤0.01%
621
-1,598
-72% -$15.9K
UGAZ
3107
DELISTED
VelocityShares 3x Long Natural Gas ETN linked to the S&P GSCI Natural Gas Index ER due February 9, 2
UGAZ
$5K ﹤0.01%
+8
New +$4.9K
RVLT
3108
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$5K ﹤0.01%
+1,192
New +$4.7K
AOI
3109
DELISTED
Alliance One International
AOI
$5K ﹤0.01%
300
-18,614
-98% -$387K
AMWD
3110
DELISTED
American Woodmark
AMWD
$4K ﹤0.01%
44
-1,718
-98% -$159K
APPN icon
3111
Appian
APPN
$2.54B
$4K ﹤0.01%
114
-7,864
-99% -$244K
BLFS icon
3112
BioLife Solutions
BLFS
$1.69B
$4K ﹤0.01%
342
+336
+5,600% +$3.06K
BSBR icon
3113
Santander
BSBR
$43.5B
$4K ﹤0.01%
496
-9,877
-95% -$92.2K
CAMT icon
3114
Camtek
CAMT
$7.25B
$4K ﹤0.01%
+564
New +$4.32K
CCBG icon
3115
Capital City Bank Group
CCBG
$890M
$4K ﹤0.01%
+151
New +$3.61K
COGT icon
3116
Cogent Biosciences
COGT
$7.24B
$4K ﹤0.01%
+71
New +$3.41K
CTOS icon
3117
Custom Truck One Source
CTOS
$2.37B
$4K ﹤0.01%
380
CUE icon
3118
Cue Biopharma
CUE
$114M
$4K ﹤0.01%
11
-3
-21% -$1.19K
CVCO icon
3119
Cavco Industries
CVCO
$4.55B
$4K ﹤0.01%
+19
New +$3.57K
CVI icon
3120
CVR Energy
CVI
$3.13B
$4K ﹤0.01%
116
-84
-42% -$3.17K
CXSE icon
3121
WisdomTree Trust WisdomTree China ex-State-Owned Enterprises Fund
CXSE
$508M
$4K ﹤0.01%
+94
New +$4.09K
DLHC icon
3122
DLH Holdings
DLHC
$69.9M
$4K ﹤0.01%
764
-651
-46% -$3.72K
DMLP icon
3123
Dorchester Minerals
DMLP
$1.26B
$4K ﹤0.01%
+198
New +$3.67K
DSX icon
3124
Diana Shipping
DSX
$301M
$4K ﹤0.01%
1,078
-638
-37% -$1.85K
ECPG icon
3125
Encore Capital Group
ECPG
$2.13B
$4K ﹤0.01%
+108
New +$4.54K

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.